Synergistic control of T cell development and tumor suppression by diacylglycerol kinase α and ζ

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 33, 2008, Pages 11909-11914

  Guo, Rishu ^a   Wan, Chi Keung ^a   Carpenter, Jeffery H ^a   Mousallem, Talal ^a   Boustany, Rose Mary N ^a,b   Kuan, Chien Tsun ^a   Burks, A Wesley ^a   Zhong, Xiao Ping ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Phosphatidic acid; Signaling; Tumorigenesis

Indexed keywords

DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE ALPHA; DIACYLGLYCEROL KINASE ZETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CD4 CD8 RATIO; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; THYMUS;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; DIACYLGLYCEROL KINASE; ENZYME ACTIVATION; FEMALE; ISOENZYMES; LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RAS PROTEINS; T-LYMPHOCYTES; THYMUS GLAND; TISSUE CULTURE TECHNIQUES;

MUS;

EID: 50149083445     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711856105     Document Type: Article

References (46)

1. Sakane F, Imai S, Kai M, Yasuda S, Kanoh H (2007) Diacylglycerol kinases: Why somany of them? Biochim Biophys Acta 1771:793-806.
2. Merida I, Avila-Flores A, Merino E (2008) Diacylglycerol kinases: At the hub of cell signalling. Biochem J 409:1-18.
3. Kazanietz MG (2002) Novel "nonkinase" phorbol ester receptors: The C1 domain connection. Mol Pharmacol 61:759-767.
4. Wang X, Devaiah SP, Zhang W, Welti R (2006) Signaling functions of phosphatidic acid. Prog Lipid Res 45:250-278.
5. Frank C, Keilhack H, Opitz F, Zschornig O, Bohmer FD (1999) Binding of phosphatidic acid to the protein-tyrosine phosphatase SHP-1 as a basis for activity modulation. Biochemistry 38:11993-12002.
6. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J (2001) Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942-1945.
7. Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 9:706-712.
8. Luo B, Prescott SM, Topham MK (2004) Diacylglycerol kinase ζ regulates phosphatidylinositol 4-phosphate 5-kinase Iα by a novel mechanism. Cell Signal 16:891-897.
9. Starr TK, Jameson SC, Hogquist KA (2003) Positive and negative selection of T cells. Annu Rev Immunol 21:139-176.
10. Hogquist KA, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17-27.
11. Ashton-Rickardt PG, et al. (1994) Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651-663.
12. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM (1995) Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373:620-623.
13. Dower NA, et al. (2000) RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol 1:317-321.
14. Werlen G, Hausmann B, Palmer E (2000) A motif in the αβ T-cell receptor controls positive selection by modulating ERK activity. Nature 406:422-426.
15. Fischer AM, Katayama CD, Pages G, Pouyssegur J, Hedrick SM (2005) The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23:431-443.
16. Mariathasan S, et al. (2001) Duration and strength of extracellular signal-regulated kinase signals are altered during positive versus negative thymocyte selection. J Immunol 167:4966-4973.
17. Daniels MA, et al. (2006) Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444:724-729.
18. Zhong XP, et al. (2002) Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase ζ. J Biol Chem 277:31089-31098.
19. Zhong XP, et al. (2003) Enhanced T cell responses due to diacylglycerol kinase ζ deficiency. Nat Immunol 4:882-890.
20. Olenchock BA, et al. (2006) Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nat Immunol 7:1174-1181.
21. Zha Y, et al. (2006) T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase α. Nat Immunol 7:1166-1173.
22. Sanjuan MA, et al. (2003) T cell activation in vivo targets diacylglycerol kinase α to the membrane: A novel mechanism for Ras attenuation. J Immunol 170:2877-2883.
23. Mombaerts P, et al. (1992) Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360:225-231.
24. Gapin L, Matsuda JL, Surh CD, Kronenberg M (2001) NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol 2:971-978.
25. Olenchock BA, et al. (2006) Impaired degranulation but enhanced cytokine production after FcεRI stimulation of diacylglycerol kinase ζ-deficient mast cells. J Exp Med 203:1471-1480.
26. von Boehmer H (1990) Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol 8:531-556.
27. Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A (2005) A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol Cell Biol 25:4426-4441.
28. Strzadala L, Miazek A, Matuszyk J, Kisielow P (1997) Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice. Int Immunol 9:127-138.
29. Swan KA, et al. (1995) Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 14:276-285.
30. Delgado P, Fernandez E, Dave V, Kappes D, Alarcon B (2000) CD3δ couples T-cell receptor signaling to ERK activation and thymocyte positive selection. Nature 406:426-430.
31. Pages G, et al. (1999) Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374-1377.
32. Klinger MB, Guilbault B, Goulding RE, Kay RJ (2005) Deregulated expression of Ras-GRP1 initiates thymic lymphomagenesis independently of T-cell receptors. Oncogene 24:2695-2704.
33. Avila-Flores A, Santos T, Rincon E, Merida I (2005) Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid. J Biol Chem 280:10091-10099.
34. Liu CH, et al. (2007) Diacylglycerol kinase ζ regulates microbial recognition and host resistance to Toxoplasma gondii. J Exp Med 204:781-792.
35. Sarbassov DD, Ali SM, Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17:596-603.
36. + T cells in the periphery. Transplant 77:183-189.
37. Berrar D, Sturgeon B, Bradbury I, Downes CS, Dubitzky W (2005) Survival trees for analyzing clinical outcome in lung adenocarcinomas based on gene expression profiles: Identification of neogenin and diacylglycerol kinase α expression as critical factors. J Comput Biol 12:534-544.
38. Kannan K, et al. (2001) DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20:2225-2234.
39. Hammond EM, et al. (2006) Genome-wide analysis of p53 under hypoxic conditions. Mol Cell Biol 26:3492-3504.
40. Ebinu JO, et al. (1998) RasGRP, a Ras guanyl nucleotide-releasing protein with calciumand diacylglycerol-binding motifs. Science 280:1082-1086.
41. Yeoh EJ, et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133-143.
42. Malumbres M, Barbacid M (2003) RAS oncogenes: The first 30 years. Nat Rev Cancer 3:459-465.
43. Evangelisti C, et al. (2007) Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts. FASEB J 21:3297-3307.
44. Los AP, et al. (2006) The retinoblastoma family proteins bind to and activate diacylglycerol kinase ζ. J Biol Chem 281:858-866.
45. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
46. Rouser G, Fkeischer S, Yamamoto A (1970) Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496.